Logging area

Recruiting

LevoTako by Medical University of Gdansk

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Levosimendan Therapy in low ejection fraction Takotsubo Syndrome (LevoTako Trial)
Recruiting

RAFTING by Medical University of Gdansk

Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTING
Recruiting

ChIm-NB-PL by Jagiellonian University Medical College

Immunotherapy with dinutuximab beta in combination with chemotherapy for the treatment of patients with primary neuroblastoma refractory to standard therapy and with relapsed or progressive disease
Recruiting

CADET-PAD by Jagiellonian University Medical College

The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endothelial function in patients undergoing endovascular treatment due to peripheral arterial disease
Recruiting

The SIBERIA II Trial by Meshalkin Research Institute of Pathology of Circulation

Independent Randomized Clinical Trial in Carotid Revascularization with MicroNet Covered Stent (CGuard) Comparing Early Neurological Outcomes with distal EPS Versus Proximal EPS. The SIBERIA II Trial
Recruiting

DuoNen by National Center for Nuclear Research, POLATOM Radioisotope Center

Tandem therapy LutaPol/ItraPol (177Lu / 90Y-DOTATATE) as an effective method in the treatment of neuroendocrine neoplasms
Recruiting

REGBONE by Institute of Mother and Child

To evaluate the efficacy and safety of regorafenib in patients with refractory primary bone tumors.
Recruiting

STOP CLOT by National Institute of Cardiology

Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial)
Recruiting

SAFE LAAC by National Institute of Cardiology

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure (SAFE-LAAC)
Recruiting

SAFE LAAC CKD by National Institute of Cardiology

Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure – Chronic Kidney Disease (SAFE LAAC CKD). Comparative Health Effectiveness Ancillary Study – PILOT
Recruiting

ARNI-ARVC by National Institute of Cardiology

Sacubitril/valsartan in preventing disease progression in patients with arrhythmogenic right ventricular cardiomyopathy - the ARNI-ARVC multi-site randomized trial
Recruiting

EMPA-REPAIR-HCM by National Institute of Cardiology

The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy
Recruiting

OPTIMAL – HT by National Institute of Cardiology

Optimal medical treatment of difficult-to-treat hypertension
Recruiting

PolBroM-PPCM by National Institute of Cardiology

Multicenter Polish Study of the Use of Bromocriptine in Perinatal Cardiomyopathy. New BioMarkers in the Early Diagnosis of Peripartum CardioMyopathy. PolBrom-PPCM
Recruiting

POSTCOVID by Eleonora Reicher National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw

Investigation of Pregabalin Therapy and Complex Rehabilitation in Treating Chronic Fatigue Associated With Post-COVID Syndrome
In preparation

CASCADES trial by National Institute of Cardiology

A randomized, ongoing, open clinical trial evaluating the anti-atherosclerotic efficacy of selected antidiabetic medications in patients with coronary artery disease and pre-diabetic conditions.
In preparation

DICES by Collegium Medicum

Diffrent Iodine Contrast media Effectiveness and Safety in Contrast Enhanced Mammography
Closed

VN21 by Medical University of Lublin

Effectiveness of Low-doses of Naltrexone (LDN) on Pain Perception and Quality of Life in Women With Vulvodynia
Loading...